Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Chief Executive Officer 63 07/09/2020
Director of Finance/CFO 54 01/01/2020
Chief Operating Officer - 01/10/2016
Director TitleAgeSince
Chairman 61 01/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.08% - - 202.31Cr
-2.41%+0.14%+38.28%+153.06% 1,01000Cr
+1.07%+3.48%+53.32%+49.09% 58TCr
+1.32%+0.22%+19.18%+67.17% 40TCr
+0.77%0.00%+21.28%+19.14% 33TCr
+0.44%+3.48%+25.65%+36.16% 28TCr
-0.85%-2.86%+22.54%+16.96% 28TCr
+1.66%+1.20%-44.35%-47.35% 20TCr
+0.32%+1.61%+20.32%+59.80% 19TCr
-0.22%-2.76%+14.19%+61.12% 16TCr
Average +0.21%+0.84%+18.93%+46.13% 38.1TCr
Weighted average by Cap. -0.23%+1.04%+27.77%+70.87%
Logo Cambrex Corporation
Cambrex Corporation (Cambrex) is a United States-based small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle. The company provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics. The Company offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and potent application program interface. In addition, it also supports conventional dosage forms including oral solids, semi-solids and liquids and has the capabilities to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!